CS2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency

Although inhibitors targeting tumor angiogenic pathway have provided improvement for clinical treatment in patients with various solid tumors, the still very limited anti‐cancer efficacy and acquired drug resistance demand new agents that may offer better clinical benefits. In the effort to find a s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Zhou, You, Shan, Song, Li, Zhi‐Bin, Xin, Li‐Jun, Pan, De‐Si, Yang, Qian‐Jiao, Liu, Ying‐Ping, Yue, Xu‐Peng, Liu, Xiao‐Rong, Gao, Ji‐Zhou, Zhang, Jin‐Wen, Ning, Zhi‐Qiang, Lu, Xian‐Ping
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378272/
https://ncbi.nlm.nih.gov/pubmed/28004478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13141
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares